CMEology

CMEology

Overview

With over 25 years in developing continuing education activities, we know how to engage health care providers. At CMEology, our ideas begin and end with the patient. Our activities embrace the National Quality Strategy and are designed to improve the effectiveness of patient care. We strive to provide meaningful learning experiences that inspire and empower. Our outcomes include quantitative assessments with descriptive statistics and subgroup analyses, qualitative results, and outcomes impact analysis and modeling.


Fact or Fiction? Test Your Readiness to Provide Nursing Care for Youth with Seizure Clusters Outside of the Hospital

Epilepsy is one of the most common chronic diseases among children and adolescents, and seizures are a frequent school health emergency. Effective rescue therapies are now available for use outside of the hospital setting to treat seizure clusters, which can progress into a seizure emergency. Nurses play a critical role in caring for youth with epilepsy, but they may find it challenging to ident...
CMEology

From Patients to People: Case Challenges in Individualizing Treatment for Adults with ADHD

In the United States, only 1 in 10 adults with ADHD receive appropriate therapy in any given year. This low number reflects the challenges that clinicians face when managing this disorder in adult patients. In particular, ADHD can manifest differently in adults than in children and teens, complicating diagnosis, especially if psychiatric comorbidities are present. Moreover, treatment strategies ...
CMEology

Implementing the APA Guidelines for the Treatment of Schizophrenia: Caring for the Whole Person

In fall 2020, the American Psychiatric Association (APA) released new practice guidelines for the treatment of patients with schizophrenia. The new guidelines were eagerly awaited, because in the 16 years since the last update, many important discoveries about schizophrenia had been made. An overarching theme in the new APA guidelines is person-centered care. This approach is critical for improv...
CMEology

Optimal Pharmacologic Treatment of ADPKD: What You Need to Know

This activity consists of three related modules on the pharmacologic management of patients with ADPKD. The modules follow a patient with ADPKD through her journey from diagnosis to consideration of therapy, initiation of treatment, and risk mitigation. In this 1.5 hour continuing education activity, internationally renowned faculty will provide key insights into assessing candidates for therapy...
CMEology

Paths to Functional Recovery in Major Depressive Disorder: Putting the Patient First A Patient-Centered Approach to Preventing, Detecting, and Managing Adverse Effects of Antidepressants

Adverse effects associated with antidepressants are common. In addition to compromising patients’ health and quality of life, they are one of the most common reasons that individuals with MDD fail to adhere to their treatment plans. To minimize the impact of antidepressant side effects on the lives of patients with MDD, clinicians require education on how to prevent, detect, and manage the mos...
CMEology

Paths to Functional Recovery in Major Depressive Disorder: Putting the Patient First Combining Patient-Centered Care for MDD with the Latest Antidepressant Efficacy to Optimize Treatment Plans

Only roughly half of patients with MDD achieve recovery after 6 months of treatment. The others continue to experience residual symptoms that impair their ability to function at work, school, and home. To ensure that more patients with MDD achieve functional recovery, clinicians require practical information about how to provide early, optimized care. In this activity, an expert faculty member w...
CMEology

Strategies for Successfully Diagnosing and Treating Tardive Dyskinesia: Enlisting the Help of Caregivers, Improving the Lives of Patients

At any given time, roughly 1 of every 4 patients taking antipsychotics experiences tardive dyskinesia (TD), a debilitating condition characterized by involuntary movements of the tongue, lips, face, trunk, and extremities. Fortunately, effective pharmacologic treatments for TD are now available. However, it can be challenging for clinicians to assess patients for TD, keep up to date on new agent...
CMEology

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map